Clinical Trials Logo

Sunscreening Agents clinical trials

View clinical trials related to Sunscreening Agents.

Filter by:

NCT ID: NCT05908435 Recruiting - Adolescent Behavior Clinical Trials

Impact of Sunscreen Dispensers in Parks Visited by Teenagers

Start date: June 3, 2023
Phase: N/A
Study type: Interventional

This study will evaluate the use of publicly available free sunscreen dispensers at Maine beaches and Boston parks. Aim 1: Determine the impact of DFS+ (dispensers, flyers, enhanced signage, + a social media component delivered by teen ambassadors) sun protection education on the use of free sunscreen dispensers by adolescents ages 12-18 compared with DFS (dispensers, flyers, standard signage). Aim 2: Outcomes evaluation to assess the effects of the sunscreen dispensers and the sun-safety educational intervention on sun protection knowledge, attitudes, beliefs, and behaviors within the community. Aim 3: Cost Evaluation and Cost-Effectiveness Analysis

NCT ID: NCT05124899 Completed - Sunscreening Agents Clinical Trials

Clinical Study to Evaluate the 80-Minute Water Resistant Sun Protection Factor (SPF) of Sunscreen Products

Start date: November 16, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the 80-Minute Water Resistant SPF of three sunscreen products (ChapStick Active Performance [CAP] UnScented, CAP Herbal Mint Flavour and CAP Mountain Berry Flavour) using the methodology described in the Food and Drug Administration (FDA) Final Rule (2011).

NCT ID: NCT05109117 Completed - Sunscreening Agents Clinical Trials

Clinical Study to Evaluate the Efficacy of an Over-the-counter (OTC) Sunscreen Lip Balm Product

Start date: December 7, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the 8-hour moisturization efficacy of OTC sunscreen lip balm after a single treatment application.

NCT ID: NCT05109104 Completed - Sunscreening Agents Clinical Trials

Clinical Study to Evaluate the Sun Protection Factor (SPF) of Three Sunscreen Products

Start date: November 8, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the static SPF of three sunscreen products (ChapStick Active Performance [CAP] UnScented, CAP Herbal Mint and CAP Mountain Berry) using the methodology described in the Food and Drug Administration (FDA) Final Rule (2011).

NCT ID: NCT05085327 Completed - Sunscreening Agents Clinical Trials

Clinical Study to Evaluate the Sun Protection Factor (SPF) of Sunscreen Products

Start date: October 19, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the static SPF of three sunscreen products (ChapStick Lip Moisturizer [CLM] Original, CLM Mint Flavour and CLM Black Cherry Flavour) using the methodology described in the Food and Drug Administration (FDA) Final Rule (2011).

NCT ID: NCT05082376 Completed - Sunscreening Agents Clinical Trials

Clinical Study to Evaluate the Efficacy of an Over-the-counter (OTC) Sunscreen Lip Balm

Start date: November 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the 8-hour moisturization efficacy of OTC sunscreen lip balm after a single treatment application.

NCT ID: NCT04749459 Completed - Sunscreening Agents Clinical Trials

Sun Protection Factor (SPF) Determination of Two Sunscreen-Containing Lip Balms

Start date: March 3, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to determine the SPF of two test materials ChapStick Moisturizer, Classic Flavor and ChapStick Moisturizer, Strawberry Flavor using the methodology described in the International Standard Test Method. This static methodology also meets the requirements of the Australia/New Zealand standard.

NCT ID: NCT04355286 Completed - Sunscreening Agents Clinical Trials

Bemotrizinol UV Filter Part 1 Clinical PK Evaluation in Topical MUsT Study

BEMT
Start date: November 3, 2020
Phase: Phase 1
Study type: Interventional

This will be a single clinical study conducted in 2 parts (Part 1: pilot study and Part 2: pivotal study). Part 1 is an open-label, 1-arm study in 14 healthy adult subjects with the following primary objectives: - Primary: To explore whether the active component, bemotrizinol (BEMT), is absorbed from a high-penetrating sunscreen formulation including 6% BEMT into the systemic circulation when applied under maximal-use conditions. - Secondary: To obtain information needed for a successful pivotal study such as preliminary pharmacokinetic (PK) data, validation of study and analytical procedures, and the number of subjects needed. Part 2 is an open-label, randomized, 3-arm study in 42 healthy adult subjects with the following objective: • Primary: To assess the systemic absorption and pharmacokinetics of BEMT from 3 market image sunscreen formulations under maximal-use conditions.

NCT ID: NCT03157583 Completed - Sunscreening Agents Clinical Trials

A Study to Measure the Sun Protection Factor (SPF) and Ultraviolet-A Protection Factor (UVAPF) of Four Developmental Sunscreen Formulations

Start date: June 21, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the SPF and UVAPF of four sunscreen formulations using international standard methodologies ISO24444:2010 for SPF and ISO24443:2012 for UVAPF.

NCT ID: NCT03136107 Completed - Sunscreening Agents Clinical Trials

Determination of the Sun Protection Factor (SPF) of a Cosmetic Daily De-fence Skin Cream

Start date: May 30, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the SPF of the test product according to the International Standards Organization (ISO) 24444:2010 methodology (In vivo determination of the SPF).